Articles & Newsletters
 
Email Page
Attorneys React to High Court's Gene Patent Ruling
Chad A. Landmon
Law360
June 13, 2013
Law360's Q&A with Axinn's Josephine Liu
Josephine Liu, Ph.D.
Law360
June 12, 2013
International Arbitration Roundtable
Thomas G. Rohback
Financier Worldwide
June 6, 2013
Lawyers Weigh In On Obama "Patent Troll" Initiatives
John D. Harkrider
Law360
June 5, 2013
Supreme Court Continues To Tackle Class Actions
Thomas G. Rohback
Law360
June 3, 2013
NY Ruling Against Goldman Pokes Hole In Diligence Defense
Donald W. Hawthorne
May 8, 2013
Axinn Partner Michael Keeley Interviewed for Law360's Q&A
Michael L. Keeley
April 30, 2013
Axinn Partner Tom Rohback Interviewed for Law360's Q&A
Thomas G. Rohback
Law360
March 26, 2013
How the Belgacom Ruling Will Impact Attorney Privilege in EU
Donald W. Hawthorne, Timothy Hirsch
Law360
March 25, 2013
Axinn Partner John D. Harkrider and Team Featured in The American Lawyer’s ‘Big Suits’ Column
John D. Harkrider
February 27, 2013
Axinn Partner Thomas G. Rohback Interviewed for Financier Worldwide's 2013 Annual Review
Thomas G. Rohback
Financier Worldwide
February 22, 2013
Satisfying the "Meet and Confer" Requirement in Federal Court
Aaron J. Feigenbaum, Nicholas E.O. Gaglio
ABA Section of Litigation
January 28, 2013
2012 Court Decisions Impact the Life Science Industry
Chad A. Landmon
January 3, 2013
The Rise of Precompetitive Collaboration
Chad A. Landmon
Life Science Leader
December 5, 2012
Generic Drug Litigation: A Growing Practice Niche
Chad A. Landmon
Connecticut Law Tribune
November 19, 2012
IP: A Prescription for Success in ITC Section 337 proceedings
Michael D. Bednarek
InsideCounsel
September 4, 2012
Closing at Your Peril: Post-Consummation Merger Challenges
Rachel J. Adcox, John D. Harkrider
The Threshold, Section of ABA Antitrust Law
Summer 2012
Getting Your Best Outcome Post-AU Optronics: Pay No Attention to That Case Behind The Curtain
Rachel J. Adcox
ABA, Section of Antitrust Law
Summer 2012
Axinn Partner Chad A. Landmon Interviewed for Law360's Q&A
Chad A. Landmon
Law360
July 12, 2012
Brand's Off-Label Promotion: Valuable Tool for Generics
Thomas K. Hedemann
Law360
Winter 2011
When the Case Is Over: A Tunney Act Primer for Defendants
Rachel J. Adcox
ABA, Young Lawyers
Winter 2011
Formulation Patents and Dermatology and Obviousness
Josephine Liu, Ph.D., Dan-Feng Mei**
November 21, 2011
Innovative Procedures v. Premarketing Approval
Chad A. Landmon, Tara R. Rahemba
HealthLaw 360 and IPLaw360
September 20, 2011
Final Word: Advocating for Biosimilar Approval Standards under BPCI
Chad A. Landmon
BioPharm International, Vol. 24, No. 9, September 2011
Machine-Or-Transformation Test After Myriad: Implications To The Prosecution Of Process Claims, Practising Law Institute, Patent Law Practice Center, August 15, 2011
Josephine Liu, Ph.D., Stacie L. Ropka, Ph.D.
Heightened Standard For The Entire Market Value Rule?
Edward M. Mathias
Law360
August 3, 2011
Do You Have The Right To Sue: Understanding Contract Provisions in The Context of Litigation
Josephine Liu, Ph.D., Tara R. Rahemba
Practicing Law Institute, Patent Law Practice Center
July 26, 2011
Viewpoint: Advocating for Biosimilar Approval Standards under BPCI
Chad A. Landmon
Pharmaceutical Technology, Vol 35, Issue 6, June 2011
Durbin Amendment Rules To Pare "Anticompetitive" Debit Card Interchange Fees
Mark D. Alexander
ABA, Section of Antitrust Law, Spring 2011
Patent Misuse: The Questions That Linger Post-Princo
American Bar Association Section of Antitrust Law Intellectual Property Committee
Spring 2011
Life in the Fast Lane - Use of the Patent Prosecution Highway
Practising Law Institute, Patent Law Practice Center
February 15, 2011
The Challenges of FDA's Nascent Biosimilars Regime
Chad A. Landmon
Law360
November 17, 2010
Human Tissue and Stem Cell Therapies: Revolutionary New Therapies that Face Increasing FDA Scrutiny
Chad A. Landmon, Tara R. Rahemba
FDLI's Update Magazine 2010, Issue 5

View Archived Articles & Newsletters ›